Admission HbA1c value as a prognostic marker in patients admitted with COVID-19

Simple item page
dc.contributor.authorJain, Vaibhaven_US
dc.contributor.authorHegde, Suraj S.en_US
dc.date.accessioned2023-08-28T06:36:35Z
dc.date.available2023-08-28T06:36:35Z
dc.date.issued2022-12
dc.description.abstractBackground:Diabetes mellitus has been firmly established as a risk factor for the prognosis of COVID-19. However, the impact of pre-COVID-19 glycemic control on prognosis is yet to be fully understood. Our study aimedto establish the effect of HbA1c at admission on the outcome of patients admitted with COVID-19.Methods:It was a prospective observational study of admitted adult patients with confirmed SARS-CoV-2 infection in a tertiary care centre based on data collected from the medical record section using the patient data registry between April 2021 to June 2021. Information regarding demographic and clinical features, laboratory values, and hospital outcomes was collected and analysed.Results:182 patients admitted to the hospital with COVID-19 during the study period were included, their mean age was 48.75 years, the mean HbA1c was 6.1. Males accounted for 69.8% (127) of the sample population. 41.2% (75) were known diabetics. 44.8% (81) were known hypertensives. The mortality rate overall was 25.3% (46). 63.7% (116) had HbA1c values >6.5.High HbA1c values was associated with longer duration of hospital stay (p=0.032), higher levels of inflammatory markers, increased need for mechanical ventilation (p=0.001), higher mortality rate (p=0.001).Conclusions:Patients with COVID-19 with poor glycemiccontrol as evidenced by admission HbA1c levels were found to have more severe disease course with increased level of inflammatory markers, longer duration of hospital stay and higher risk of mortalityen_US
dc.identifier.affiliationsDepartment of General Medicine, SIMS andRC, Mangalore, Karnataka, Indiaen_US
dc.identifier.citationJain Vaibhav, Hegde Suraj S.. Admission HbA1c value as a prognostic marker in patients admitted with COVID-19. International Journal of Advances in Medicine. 2022 Dec; 9(12): 1188-1193en_US
dc.identifier.issn2349-3933
dc.identifier.issn2349-3925
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/225928
dc.languageenen_US
dc.publisherMedip Academyen_US
dc.relation.issuenumber12en_US
dc.relation.volume9en_US
dc.source.urihttps://dx.doi.org/10.18203/2349-3933.ijam20223020en_US
dc.subjectCOVID-19en_US
dc.subjectDiabetes mellitusen_US
dc.subjectGlycated hemoglobinen_US
dc.subjectHbA1cen_US
dc.subjectHypertensionen_US
dc.subjectInflammationen_US
dc.subjectEndothelial glycocalyxen_US
dc.titleAdmission HbA1c value as a prognostic marker in patients admitted with COVID-19en_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
IJAM2022v9n12p1188.pdf
Size:
473.11 KB
Format:
Adobe Portable Document Format
Download
Collections
International Journal of Advances in Medicine